AI-ECG Tracker vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Carewell Health
VS

AI Verdict

Tool A, AI-ECG Tracker, focuses on comprehensive 12-lead ECG auto-analysis for a wide range of cardiac abnormalities, providing detailed diagnostic classifications. In contrast, Tool B, Eko Low Ejection Fraction Tool (ELEFT), is a targeted screening tool for early detection of low ejection fraction, integrating with Eko digital stethoscopes to analyze ECG and heart sound recordings during routine physical exams. While both utilize AI for cardiac assessment, AI-ECG Tracker is suited for detailed diagnosis of multiple conditions, whereas ELEFT serves as a specific early heart failure risk identification tool.

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your practice requires comprehensive, high-accuracy AI-powered analysis of full 12-lead ECG data for a wide spectrum of cardiac abnormalities. This tool is ideal for settings needing rapid, detailed diagnostic support for conditions like arrhythmias, myocardial ischemia, and infarction, with robust on-premise processing capabilities.

View AI-ECG Tracker →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your goal is to integrate an early, non-invasive screening tool for heart failure risk into routine physical examinations. This solution is best suited for clinicians looking to leverage digital stethoscopes to quickly identify patients with potential low ejection fraction, aiding in proactive heart care.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Tracker Eko Low Ejection Fraction Tool (ELEFT)
Deployment Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Low Ejection Fraction Tool (ELEFT)

Tool B (Eko Low Ejection Fraction Tool) offers a more immediate and integrated point-of-care experience by leveraging familiar digital stethoscopes for rapid screening during routine physical exams. While Tool A (AI-ECG Tracker) provides faster diagnosis (3 seconds), its on-premise workstation and dedicated client suggest a more specialized workflow compared to Tool B's seamless integration into general physical exams.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are FDA-cleared and offer significant clinical value. Tool A provides comprehensive ECG analysis for a broad range of abnormalities with high reported accuracy. However, Tool B is specifically designed for the early detection of low ejection fraction, a critical indicator of heart failure, and is supported by prospective multicenter clinical validation studies demonstrating specific sensitivity and specificity.

Pricing & Value

Eko Low Ejection Fraction Tool (ELEFT)

Neither tool provides publicly available pricing, making a direct cost comparison impossible. However, Tool B, as part of the SENSORAu2122 platform, has established a clear pathway for reimbursement through CMS recognition and anticipated CPT codes, enhancing its value proposition for healthcare providers by enabling cost recovery. Tool A lacks this transparency regarding reimbursement mechanisms.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

Both tools demonstrate strong enterprise readiness. Tool A offers flexible deployment options (on-premise and cloud) and is backed by a global company. Tool B explicitly positions itself as an 'enterprise solution,' is cloud-native, and provides clear statements on HIPAA compliance and BAA, along with dedicated enterprise support resources.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

While Tool A is innovative in its high-accuracy, rapid, and comprehensive ECG analysis, Tool B demonstrates a more disruptive innovation. By integrating an AI algorithm with a ubiquitous clinical tool like the stethoscope for early, non-invasive heart failure detection at the point of care, Tool B significantly democratizes access to advanced cardiac screening.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Tool B (Eko Low Ejection Fraction Tool) provides a well-defined support structure, including a dedicated SENSORAu2122 Help Center for enterprise users, multiple contact channels (email, phone, chat), and comprehensive documentation like user manuals and FAQs. While Tool A's parent company offers general support, specific support details for the AI-ECG Tracker product are less explicit.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Tracker Eko Low Ejection Fraction Tool (ELEFT)
Company Shenzhen Carewell Electronics Co. Eko Health
Tagline Forever Innovation Forever Care! Your new partner in precise, proactive heart and lung care.
Key Functionality AI-powered ECG auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. Supports 12-lead ECG data collection. AI-powered low ejection fraction detection by analyzing ECG and heart sound recordings, integrated with FDA-cleared Eko digital stethoscopes.
Diagnosis Speed Approximately 3 seconds Approximately 15 seconds
Specialties Array Array

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The AI-ECG Tracker is designed for comprehensive AI-powered auto-analysis and diagnosis of 104 ECG diagnostic classifications, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. In contrast, the Eko Low Ejection Fraction Tool (ELEFT) is an AI algorithm specifically developed to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
The AI-ECG Tracker supports 12-lead ECG data collection and uses an AI-ECG Workstation with a powerful GPU for fast computing. The Eko Low Ejection Fraction Tool (ELEFT) integrates with FDA-cleared Eko digital stethoscopes to analyze both ECG and heart sound recordings, with cloud-based data processing and storage.
The AI-ECG Tracker provides rapid diagnosis in approximately 3 seconds for comprehensive ECG auto-analysis. The Eko Low Ejection Fraction Tool (ELEFT) delivers results for low ejection fraction detection in approximately 15 seconds during a routine physical exam.
The AI-ECG Tracker boasts high accuracy (over 95%) for common cardiac abnormalities and provides comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. The Eko Low Ejection Fraction Tool (ELEFT) specifically aids in the early identification of heart failure risk by detecting low ejection fraction, with clinical validation showing strong ability to differentiate between low and normal EF.

Backers

Who funded each tool's parent company.

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.